Roferon-A in Combination with Tigason in Cutaneous T-Cell Lymphomas
Brigitte Dréno(Nantes Université), P Litoux(Nantes Université), P. Celérier(Centre Hospitalier de La Rochelle)
Cited by 25
Related Papers
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
|New England Journal of Medicine|2011|7.7k
Combined Vemurafenib and Cobimetinib in <i>BRAF</i> -Mutated Melanoma
|New England Journal of Medicine|2014|2k
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
|Journal of Clinical Oncology|2000|1.3k